This article is educational and does not replace medical advice. Prescription medication requires review by a licensed clinician and, when appropriate, a valid prescription. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before marketing. Treatment eligibility is an individual clinical decision.
This page is maintained. Prices are re-read at source and dated; evidence is checked against the published trial. Newest across the site: news · research · corrections.
Microdose semaglutide: evidence and reality
Quick answer
"Microdose" semaglutide means using doses below the standard label schedule. It is not an FDA-approved protocol, and rigorous evidence for below-label regimens is limited. Any low-dose approach should be clinician-directed, not self-managed.
What it means
Below-label dosing, often marketed for gentler side effects or maintenance. The term is a marketing convention, not a defined medical protocol.
The evidence
Pivotal trials used specific escalation schedules. Evidence for the efficacy of deliberately low 'microdose' regimens is limited; benefits and risks are individual.
Frequently asked questions
Does microdose semaglutide work?
Evidence for below-label 'microdosing' is limited. Some patients use lower doses under clinician direction, but it is not a proven standardized protocol.
Sources
- U.S. Food and Drug Administration — labels and safety communications.
- Peer-reviewed clinical trials cited above.
- Our methodology and medical review policy.
How the dates on this page work. Manufacturer self-pay prices — NovoCare and LillyDirect — were re-read on the manufacturers’ own published price guides on 4 August 2026. Figures captured from third-party provider websites carry the date we read that provider’s page, which may be earlier; where it is, the row says so. We do not restamp a figure we have not re-read.